Dowling & Yahnke LLC Organon & Co. Transaction History

Dowling & Yahnke LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $9,529 - $11,708	-301 Reduced 4.55%	6,309 $213,000
Q1 2022 May 04, 2022	SELL	$30.45 - $39.36 $18,056 - $23,340	-593 Reduced 8.23%	6,610 $231,000
Q4 2021 Feb 10, 2022	SELL	$28.67 - $37.13 $30,619 - $39,654	-1,068 Reduced 12.91%	7,203 $219,000
Q3 2021 Nov 12, 2021	SELL	$28.63 - $35.64 $57,088 - $71,066	-1,994 Reduced 19.43%	8,271 $271,000
Q2 2021 Jul 21, 2021	BUY	$28.45 - $38.0 $292,039 - $390,070	10,265 New	10,265 $311,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

Stay updated on Dowling & Yahnke LLC with notifications on news.